AMCP Statement of Support for FDA Commissioner Dr. Robert Califf
Alexandria, Va., Feb. 15, 2022 — Following the U.S. Senate’s confirmation of Robert Califf, MD, MACC, as Commissioner of the U.S. Food and Drug Administration (FDA), AMCP offered the following statement of support:
"AMCP congratulates Dr. Robert Califf on his confirmation as Commissioner of the FDA. Dr. Califf has already proven himself as a leader during his first tenure as FDA Commissioner under the Obama administration, and we look forward to continuing our work with him and the FDA to help people get the medications they need at a cost they can afford."
AMCP CEO Susan Cantrell, MHL, RPh, CAE, added, “Dr. Califf will use his decades of experience to take the lead in addressing many of the issues that are prevalent in managed care pharmacy. I am encouraged and impressed by his research on chronic conditions that disproportionately affect people of color as it aligns with aligns with AMCP’s strategic priority to address racial health disparities.”
AMCP is the professional association leading the way to help patients get the medications they need at a cost they can afford. AMCP’s diverse membership of pharmacists, physicians, nurses, biopharmaceutical professionals, and other stakeholders leverage their specialized expertise in clinical evidence and economics to optimize medication benefit design and population health management and help patients access cost-effective and safe medications and other drug therapies. AMCP members improve the lives of nearly 300 million Americans served by private and public health plans, pharmacy benefit management firms, and emerging care models. Visit www.amcp.org.